Phase 2 SCLC Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
Advanced Solid TumorsSCLCHRD Cancer
National Cancer Institute (NCI)120 enrolled1 locationNCT04826341
Recruiting
Phase 1Phase 2
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
TNBC - Triple-Negative Breast CancerAdvanced Solid TumorsNSCLC+3 more
Tubulis GmbH250 enrolled16 locationsNCT06657222
Recruiting
Phase 2
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
SCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences20 enrolled2 locationsNCT07110103
Recruiting
Phase 2
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
NSCLCSCLC
Zhejiang Provincial People's Hospital260 enrolled1 locationNCT06534762
Recruiting
Phase 2
Adebrelimab + Apatinib in SCLC Maintenance Therapy
SCLC
Tang-Du Hospital60 enrolled1 locationNCT06475209